<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:38:22Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9481656" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9481656</identifier>
        <datestamp>2022-10-14</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3-mathml3.xsd" dtd-version="1.3" id="pst2209" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Pharm Stat</journal-id>
              <journal-id journal-id-type="iso-abbrev">Pharm Stat</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1539-1612</journal-id>
              <journal-id journal-id-type="publisher-id">PST</journal-id>
              <journal-title-group>
                <journal-title>Pharmaceutical Statistics</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1539-1604</issn>
              <issn pub-type="epub">1539-1612</issn>
              <publisher>
                <publisher-name>John Wiley &amp; Sons, Inc.</publisher-name>
                <publisher-loc>Chichester, UK</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9481656</article-id>
              <article-id pub-id-type="pmcid">PMC9481656</article-id>
              <article-id pub-id-type="pmc-uid">9481656</article-id>
              <article-id pub-id-type="pmid">35332674</article-id>
              <article-id pub-id-type="pmid">35332674</article-id>
              <article-id pub-id-type="doi">10.1002/pst.2209</article-id>
              <article-id pub-id-type="publisher-id">PST2209</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Main Paper</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Main Papers</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title><styled-content style="fixed-case" toggle="no">SCI</styled-content>: A Bayesian adaptive phase I/<styled-content style="fixed-case" toggle="no">II</styled-content> dose‐finding design accounting for <styled-content style="fixed-case" toggle="no">semi‐competing</styled-content> risks outcomes for immunotherapy trials</article-title>
                <alt-title alt-title-type="left-running-head">Zhang et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="pst2209-cr-0001" contrib-type="author">
                  <name>
                    <surname>Zhang</surname>
                    <given-names>Yifei</given-names>
                  </name>
                  <xref rid="pst2209-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="pst2209-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="pst2209-cr-0002" contrib-type="author">
                  <name>
                    <surname>Guo</surname>
                    <given-names>Beibei</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9921-5535</contrib-id>
                  <xref rid="pst2209-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="pst2209-cr-0003" contrib-type="author">
                  <name>
                    <surname>Cao</surname>
                    <given-names>Sha</given-names>
                  </name>
                  <xref rid="pst2209-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="pst2209-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="pst2209-cr-0004" contrib-type="author">
                  <name>
                    <surname>Zhang</surname>
                    <given-names>Chi</given-names>
                  </name>
                  <xref rid="pst2209-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <xref rid="pst2209-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="pst2209-cr-0005" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Zang</surname>
                    <given-names>Yong</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5036-5815</contrib-id>
                  <xref rid="pst2209-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="pst2209-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <address>
                    <email>zangy@iu.edu</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="pst2209-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Statistics and Programming</named-content>
                <institution>Jiangsu Hengrui Pharmaceuticals Co. Ltd.</institution>
                <city>Shanghai</city>
                <country country="CN">China</country>
              </aff>
              <aff id="pst2209-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Department of Biostatistics and Health Data Science</named-content>
                <institution>Indiana University</institution>
                <city>Indianapolis</city>
                <named-content content-type="country-part">Indiana</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="pst2209-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Department of Experimental Statistics</named-content>
                <institution>Louisiana State University</institution>
                <city>Baton Rouge</city>
                <named-content content-type="country-part">Louisiana</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="pst2209-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Center of Computational Biology and Bioinformatics</named-content>
                <institution>Indiana University</institution>
                <city>Indianapolis</city>
                <named-content content-type="country-part">Indiana</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="pst2209-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Medical and Molecular Genetics</named-content>
                <institution>Indiana University</institution>
                <city>Indianapolis</city>
                <named-content content-type="country-part">Indiana</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Yong Zang, Department of Biostatistics and Health Data Sciences, Indiana University, 410 W 10th Street, Indianapolis, IN 46075, USA.<break/>
Email: <email>zangy@iu.edu</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>24</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <season>Sep-Oct</season>
                <year>2022</year>
              </pub-date>
              <volume>21</volume>
              <issue seq="120">5</issue>
              <issue-id pub-id-type="doi">10.1002/pst.v21.5</issue-id>
              <fpage>960</fpage>
              <lpage>973</lpage>
              <history>
                <date date-type="rev-recd">
                  <day>11</day>
                  <month>1</month>
                  <year>2022</year>
                </date>
                <date date-type="received">
                  <day>29</day>
                  <month>10</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>07</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2022 John Wiley & Sons, Ltd.-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. <italic toggle="yes">Pharmaceutical Statistics</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:PST-21-960.pdf"/>
              <abstract>
                <title>Abstract</title>
                <p>An immunotherapy trial often uses the phase I/II design to identify the optimal biological dose, which monitors the efficacy and toxicity outcomes simultaneously in a single trial. The progression‐free survival rate is often used as the efficacy outcome in phase I/II immunotherapy trials. As a result, patients developing disease progression in phase I/II immunotherapy trials are generally seriously ill and are often treated off the trial for ethical consideration. Consequently, the happening of disease progression will terminate the toxicity event but not vice versa, so the issue of the semi‐competing risks arises. Moreover, this issue can become more intractable with the late‐onset outcomes, which happens when a relatively long follow‐up time is required to ascertain progression‐free survival. This paper proposes a novel Bayesian adaptive phase I/II design accounting for semi‐competing risks outcomes for immunotherapy trials, referred to as the dose‐finding design accounting for semi‐competing risks outcomes for immunotherapy trials (SCI) design. To tackle the issue of the semi‐competing risks in the presence of late‐onset outcomes, we re‐construct the likelihood function based on each patient's actual follow‐up time and develop a data augmentation method to efficiently draw posterior samples from a series of Beta‐binomial distributions. We propose a concise curve‐free dose‐finding algorithm to adaptively identify the optimal biological dose using accumulated data without making any parametric dose–response assumptions. Numerical studies show that the proposed SCI design yields good operating characteristics in dose selection, patient allocation, and trial duration.</p>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="pst2209-kwd-0001">adaptive design</kwd>
                <kwd id="pst2209-kwd-0002">immunotherapy</kwd>
                <kwd id="pst2209-kwd-0003">late‐onset outcome</kwd>
                <kwd id="pst2209-kwd-0004">phase I/II clinical trial</kwd>
                <kwd id="pst2209-kwd-0005">semi‐competing risks</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Science Foundation
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100008982</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>Indiana University
</institution>
                      <institution-id institution-id-type="doi">10.13039/100006733</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>Louisiana Board of Regents
</institution>
                      <institution-id institution-id-type="doi">10.13039/100006952</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institutes of Health
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>CA264257</award-id>
                  <award-id>R21</award-id>
                  <award-id>CA082709</award-id>
                  <award-id>P30</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="3"/>
                <table-count count="1"/>
                <page-count count="14"/>
                <word-count count="6341"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>September/October 2022</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.0 mode:remove_FC converted:07.10.2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="pst2209-cit-9001"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Guo</surname><given-names>B</given-names></string-name>, <string-name><surname>Cao</surname><given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C</given-names></string-name>, <string-name><surname>Zang</surname><given-names>Y</given-names></string-name>. <article-title><styled-content style="fixed-case" toggle="no">SCI</styled-content>: A Bayesian adaptive phase I/<styled-content style="fixed-case" toggle="no">II</styled-content> dose‐finding design accounting for <styled-content style="fixed-case" toggle="no">semi‐competing</styled-content> risks outcomes for immunotherapy trials</article-title>. <source>Pharmaceutical Statistics</source>. <year>2022</year>;<volume>21</volume>(<issue>5</issue>):<fpage>960</fpage>‐<lpage>973</lpage>. doi:<pub-id pub-id-type="doi">10.1002/pst.2209</pub-id>
<pub-id pub-id-type="pmid">35332674</pub-id></mixed-citation>
              </p>
              <fn-group>
                <fn id="pst2209-note-1002">
                  <p><bold>Funding information</bold> National Science Foundation; Indiana University; Louisiana Board of Regents; National Institutes of Health, Grant/Award Numbers: CA264257, R21, CA082709, P30</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="pst2209-body-0001">
            <sec id="pst2209-sec-0001">
              <label>1</label>
              <title>INTRODUCTION</title>
              <p>Immunotherapy (IT) has changed the direction of cancer care.<xref rid="pst2209-bib-0001" ref-type="bibr"><sup>1</sup></xref> Unlike cytotoxic agents, which attack tumor cells directly, IT boosts the body's natural defenses to fight cancer and represents the most promising new cancer treatment approach since the first chemotherapies' development in the late 1940s.<xref rid="pst2209-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="pst2209-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="pst2209-bib-0004" ref-type="bibr"><sup>4</sup></xref> There are several types of IT, including monoclonal antibodies, non‐specific immunotherapies, oncolytic virus therapy, T‐cell therapy, and cancer vaccines. IT has already led to major treatment breakthroughs for several cancers, including brain cancer, breast cancer, bladder cancer, and other types of cancer.<xref rid="pst2209-bib-0005" ref-type="bibr"><sup>5</sup></xref>
</p>
              <p>The emergence of IT has challenged the assumption that both efficacy and toxicity response rates increase monotonically with the dose, which most of the phase I dose‐finding trials rely on to identify the maximum tolerated dose (MTD) solely based on toxicity outcomes. Indeed, IT enhances the immune system's innate power to stop the growth of cancer cells and prevent cancer from spreading to other parts of the body. Consequently, IT is not necessarily administered at its MTD to achieve an optimal therapeutic effect, making the conventional phase I trial design targeting MTD inappropriate for IT trials. Instead, the primary goal of a dose‐finding trial for IT is to identify the optimal biological dose (OBD), which achieves the optimal overall therapeutic effect among all the candidate doses. To find the OBD for IT requires monitoring both the toxicity and efficacy outcomes in a single trial, which is typically referred to as the phase I/II clinical trial.<xref rid="pst2209-bib-0006" ref-type="bibr"><sup>6</sup></xref>
</p>
              <p>Due to different biological mechanisms of cytotoxic agents (e.g., radiotherapy and chemotherapy) and IT, the definitions of the efficacy responses also differ. In general, a patient responds favorably to a cytotoxic agent if he/she has achieved at least partial remission of the tumor after receiving the treatment. On the other hand, because IT aims to stop the growth of tumors rather than kill the cancer cell, stable disease is often considered a positive signal, and only the occurrence of disease progression is treated as a negative efficacy response.<xref rid="pst2209-bib-0007" ref-type="bibr"><sup>7</sup></xref> As a result, the progression‐free survival rate rather than the objective tumor response rate is often used as the efficacy outcome in the IT trial.</p>
              <p>Using the progression‐free survival rate as the response outcome in a phase I/II dose‐finding trial causes many essential and practical issues. First of all, patients developing disease progression in oncology trials are typically seriously ill. Indeed, many patients will develop cancer‐related death sooner after experiencing disease progression. Even if not, they will be treated off the trial with other second‐line drugs because it is highly unethical to continue treating a seriously ill patient with an ineffective drug. Consequently, if the toxicity event does not happen before the disease progression, it will be censored at the disease progression time. In other words, the happening of disease progression will terminate the happening of toxicity, but not vice versa. In the statistical community, this kind of data is often referred to as the semi‐competing risks data.<xref rid="pst2209-bib-0008" ref-type="bibr"><sup>8</sup></xref> Secondly, the evaluation of progression‐free survival rate requires a relatively long follow‐up time compared with evaluating the objective tumor response rate, which may cause the late‐onset outcome issue in addition to the semi‐competing risks. The late‐onset happens when at least part of the patients' response outcomes are missing due to incomplete follow‐up at the interim analysis time and maybe ascertainable long after that time. The missing data caused by late‐onset in a dose‐finding trial are not‐missing‐at‐random and should be appropriately handled to avoid biased statistical inference.<xref rid="pst2209-bib-0009" ref-type="bibr"><sup>9</sup></xref> The naive solution of temporarily suspending the trial to allow all enrolled patients to be fully evaluated before a new dose assignment is often unrealistic because it may result in an unfeasibly long trial, wastes resources, and causes a tremendous administrative burden. Besides, it is ethically undesirable to delay a new patient's treatment while waiting for previous patients' outcomes.</p>
              <p>We develop a novel Bayesian adaptive dose‐finding design accounting for semi‐competing risks outcomes for IT trials in the presence of late‐onset issue. We first decompose the joint toxicity‐efficacy probability into the product of marginal and conditional probabilities and then re‐construct the likelihood function based on each patient's actual follow‐up time. We also develop a data augmentation method to efficiently draw the posterior samples for the parameters of interest from a series of beta‐binomial distributions,<xref rid="pst2209-bib-0010" ref-type="bibr"><sup>10</sup></xref> which substantially reduces the computational burden. We propose a curve‐free dose‐finding algorithm to adaptively identify the OBD based on a toxicity‐efficacy tradeoff function, making no parametric model assumptions on the dose–response relationships.</p>
              <p>Our research is motivated by a phase I/II IT trial conducted at Indiana University Melvin and Bren Simon Comprehensive Cancer Center. This trial aims to find the OBD for a novel programmed cell death protein 1 (PD‐1) immune checkpoint inhibitor for patients with acute myeloid leukemia (AML) and high‐risk myelodysplasia. This inhibitor acts to inhibit the association of the programmed death‐ligand 1 with its receptor PD‐1, which is involved in suppressing the patient's immune system.<xref rid="pst2209-bib-0011" ref-type="bibr"><sup>11</sup></xref> Five dose levels (0.1, 0.3, 0.5, 0.8, 1.0 mg/kg) of the inhibitor will be investigated, and the prepared doses will be administered by slow injection over 10 min. A maximum of 60 patients will be accrued to the trial. The primary efficacy outcome is the 1‐year progression‐free survival rate. The co‐primary toxicity outcome is the grade 3 and 4 hematological and non‐hematological toxicity rate associated with treatment, which will also be ascertained in a 1‐year period. Any patients experiencing disease progression will be treated off the trial with the second‐line treatment azacitidine, confounding the toxicity outcome's evaluation. Hence, the issue of semi‐competing risks arises. In addition, a new cohort of patients will enter the trial every 6 months for dose allocation before all the toxicity and efficacy outcomes become available for previous patients in the trial. Therefore, this IT trial is also subject to the late‐onset issue. Designing a rigorous and efficient dose‐finding trial handling late‐onset semi‐competing risks toxicity‐efficacy outcomes is the challenge of this study.</p>
              <p>Many phase I/II clinical trial designs for IT have been proposed in the literature. For categorical outcome, Messer et al.<xref rid="pst2209-bib-0012" ref-type="bibr"><sup>12</sup></xref> proposed a toxicity evaluation design for IT trials, which is based on safety hypothesis testing and an algorithm similar to a 3 + 3 design. Liu and Johnson<xref rid="pst2209-bib-0013" ref-type="bibr"><sup>13</sup></xref> developed a robust phase I/II dose‐finding design that modeled the toxicity and efficacy using a flexible Bayesian dynamic model and borrowed information across doses without imposing stringent parametric assumptions on the shape of the dose‐toxicity and dose‐efficacy curves. Lin and Yin<xref rid="pst2209-bib-0014" ref-type="bibr"><sup>14</sup></xref> proposed the STEIN design as the first toxicity‐efficacy interval design for optimal dose‐finding trials considering both efficacy and toxicity outcomes. Liu et al.<xref rid="pst2209-bib-0015" ref-type="bibr"><sup>15</sup></xref> developed a latent variable model to capture the correlations of the toxicity and efficacy outcomes in a phase I/II trial. Zhou et al.<xref rid="pst2209-bib-0016" ref-type="bibr"><sup>16</sup></xref> developed a utility‐based Bayesian optimal interval (U‐BOIN) design to identify the OBD. Han et al.<xref rid="pst2209-bib-0017" ref-type="bibr"><sup>17</sup></xref> developed a two‐stage nonparametric dose‐finding design (TSNP) for IT trial. For late‐onset outcomes, Liu et al.<xref rid="pst2209-bib-0018" ref-type="bibr"><sup>18</sup></xref> treated the late‐onset outcomes as missing data and proposed a data augmentation algorithm to impute the missing data under the Bayesian framework. The work was further extended by Jin et al.<xref rid="pst2209-bib-0019" ref-type="bibr"><sup>19</sup></xref> to the phase I/II trial design considering both toxicity and efficacy outcomes. Zhang and Zang<xref rid="pst2209-bib-0020" ref-type="bibr"><sup>20</sup></xref> proposed a conditional weighted likelihood (CWL) method to address the jointly late‐onset toxicity‐efficacy outcomes issue without making any parametric model assumption. To the best of our knowledge, this paper presents the first phase I/II clinical trial design for IT that accounts for semi‐competing risks late‐onset outcomes.</p>
              <fig position="float" fig-type="FIGURE" id="pst2209-fig-0001">
                <label>FIGURE 1</label>
                <caption>
                  <p>Illustration of the late‐onset mechanism. The solid circle indicates that the event does not happen at the end of the follow‐up. The hollow circle indicates that the event is missing. The solid triangle indicates that the event has happened</p>
                </caption>
                <graphic xlink:href="PST-21-960-g001" position="anchor" id="jats-graphic-1"/>
              </fig>
              <p>We have previously developed another Bayesian adaptive design for phase I/II clinical trials with late‐onset outcomes.<xref rid="pst2209-bib-0021" ref-type="bibr"><sup>21</sup></xref> The differences between the previous one and the new design proposed in this paper are listed as follows. (1) We consider the competing‐risk late‐onset outcomes in the previous design where either the happening of disease progression or dose‐limiting toxicity will terminate the follow‐up for another event. In this paper, we focus on the semi‐competing risk late‐onset outcomes such that only the happening of disease progression can early terminate a patient's follow‐up. (2) We use a piece‐wise cause‐specific hazard model to characterize the late‐onset competing risk outcome in the previous paper and propose to use the uniform distribution to approximate the late‐onset semi‐competing risk outcome in this paper. (3) We use a parametric continuation‐ratio to capture the correlation between the toxicity and efficacy outcomes in the previous design and use the strategy of decomposing the joint distribution into the marginal and conditional distributions in this paper without any parametric model assumption.</p>
            </sec>
            <sec id="pst2209-sec-0002">
              <label>2</label>
              <title>PROBABILITY MODEL</title>
              <p>We first investigate the bias caused by semi‐competing risks. Let <mml:math id="jats-math-1" display="inline"><mml:mi>Y</mml:mi></mml:math> be the response outcomes. In the presence of semi‐competing risks, <mml:math id="jats-math-2" display="inline"><mml:mi>Y</mml:mi></mml:math> has four levels, with <mml:math id="jats-math-3" display="inline"><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math>, if no adverse event occurs; <mml:math id="jats-math-4" display="inline"><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:math>, if the disease progression (DP) event occurs first; <mml:math id="jats-math-5" display="inline"><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:math>, if only the dose‐limiting toxicity (DLT) event occurs; <mml:math id="jats-math-6" display="inline"><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:math>, if the DLT event occurs first followed by the DP event. Let <mml:math id="jats-math-7" display="inline"><mml:mi>d</mml:mi></mml:math> be the dose levels under investigation, we can define <mml:math id="jats-math-8" display="inline"><mml:msub><mml:mi>p</mml:mi><mml:mi mathvariant="italic">jk</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>Y</mml:mi><mml:mo>=</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:math>, which can be naturally estimated from the observed data.</p>
              <p>We use <italic toggle="yes">Y</italic>
<sub>P</sub> and <italic toggle="yes">Y</italic>
<sub>T</sub> to denote the binary DP and DLT outcomes. Let <italic toggle="yes">Y</italic>
<sub>P</sub> = 1 denote DP occurring, 0 otherwise. Similarly, let <italic toggle="yes">Y</italic>
<sub>T</sub> = 1 denote DLT occurring, 0 otherwise. Let <mml:math id="jats-math-9" display="inline"><mml:msub><mml:mi>π</mml:mi><mml:mi mathvariant="italic">lsk</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators=",|"><mml:mrow><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:math> be the joint probability of interest for <mml:math id="jats-math-10" display="inline"><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:math> and <mml:math id="jats-math-11" display="inline"><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>…</mml:mi><mml:mo>,</mml:mo><mml:mi>K</mml:mi></mml:math>. Then, after denoting <mml:math id="jats-math-12" display="inline"><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:mi>DP</mml:mi><mml:mspace width="0.5em"/><mml:mtext>occurs</mml:mtext><mml:mspace width="0.5em"/><mml:mtext>first</mml:mtext><mml:mo>∣</mml:mo><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:math>, The relationships between <mml:math id="jats-math-13" display="inline"><mml:msub><mml:mi>p</mml:mi><mml:mi mathvariant="italic">jk</mml:mi></mml:msub></mml:math> and <mml:math id="jats-math-14" display="inline"><mml:msub><mml:mi>π</mml:mi><mml:mi mathvariant="italic">lsk</mml:mi></mml:msub></mml:math> are:<disp-formula id="pst2209-disp-0001"><label>(1)</label><mml:math id="jats-math-15" display="block"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>00</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>;</mml:mo><mml:mspace width="0.5em"/><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>10</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>;</mml:mo><mml:mspace width="0.5em"/><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>01</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>;</mml:mo><mml:mspace width="0.5em"/><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:math></disp-formula>Noticing that <mml:math id="jats-math-16" display="inline"><mml:msub><mml:mi>π</mml:mi><mml:mi mathvariant="italic">lsk</mml:mi></mml:msub></mml:math> are the real parameters of interest and <mml:math id="jats-math-17" display="inline"><mml:msub><mml:mi>p</mml:mi><mml:mi mathvariant="italic">jk</mml:mi></mml:msub></mml:math> are the parameters subject to semi‐competing risks issue. Therefore, when the issue of the semi‐competing risks arises (<mml:math id="jats-math-18" display="inline"><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:math>), it will distort the estimates of the joint probabilities <mml:math id="jats-math-19" display="inline"><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>10</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> and <mml:math id="jats-math-20" display="inline"><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math>. In terms of the marginal estimates, let us define <mml:math id="jats-math-21" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Pk</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>10</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> as the DP rate and <mml:math id="jats-math-22" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>01</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> as the DLT rate. Then, if the semi‐competing risks issue is ignored, the DP rate and DLT rate will be represented by <mml:math id="jats-math-23" display="inline"><mml:msub><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo stretchy="true">˜</mml:mo></mml:mover><mml:mi mathvariant="italic">Pk</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Pk</mml:mi></mml:msub></mml:math> and <mml:math id="jats-math-24" display="inline"><mml:msub><mml:mover accent="true"><mml:mi>q</mml:mi><mml:mo stretchy="true">˜</mml:mo></mml:mover><mml:mi mathvariant="italic">Tk</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Tk</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi mathvariant="italic">ϕπ</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Tk</mml:mi></mml:msub></mml:math> so the estimate for the DLT rate will also be biased. Since the toxicity outcome (DLT) is necessary for almost any phase I and phase I/II dose‐finding trial, the issue of the semi‐competing risks must be appropriately addressed.</p>
              <p>The semi‐competing risks problem is often nested with the late‐onset issue for clinical trials because of the long follow‐up time of the response outcomes. We now investigate the late‐onset issue. First of all, in Figure <xref rid="pst2209-fig-0001" ref-type="fig">1</xref>, we provide an illustrative example to demonstrate the late‐onset mechanism. In Figure <xref rid="pst2209-fig-0001" ref-type="fig">1</xref>, a new patient will be enrolled in the trial at the beginning of every month. Once enrolled, that patient will be followed for 2 months to ascertain the DP and DLT information. When the second patient enters the trial, the first patient has only been followed for 1 month and does not experience DP or DLT, so the late‐onset issue rises. When the third patient enters the trial, the first patient has been fully followed with <mml:math id="jats-math-25" display="inline"><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math> and <mml:math id="jats-math-26" display="inline"><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math>. However, the second patient is still under follow‐up and is subject to the late‐onset issue. The third patient's toxicity‐efficacy information is missing when the last patient comes in due to the late‐onset issue. The second patient has now been fully followed and has developed DP in his/her 1.5 months follow‐up time. However, his/her DLT status is missing, but that is due to the semi‐competing risks issue rather than the late‐onset, and that information will always be unobservable even if the second patient has been fully followed. Because the semi‐competing risks can distort the estimates and the late‐onset issue is also non‐ignorable,<xref rid="pst2209-bib-0009" ref-type="bibr"><sup>9</sup></xref>, <xref rid="pst2209-bib-0021" ref-type="bibr"><sup>21</sup></xref> a new method is needed to solve these entangled problems, which will be developed in the following content.</p>
              <p>Let <italic toggle="yes">U</italic>
<sub>T</sub> and <italic toggle="yes">U</italic>
<sub>P</sub> be the fixed total follow‐up time for DLT and DP. We define <mml:math id="jats-math-27" display="inline"><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:math> and <mml:math id="jats-math-28" display="inline"><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:math> as the actual follow‐up time for DLT and DP for the <italic toggle="yes">i</italic>th patient assigned to dose level <italic toggle="yes">k</italic> at an interim analysis time and we have <mml:math id="jats-math-29" display="inline"><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:math> and <mml:math id="jats-math-30" display="inline"><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:math> by trial design. Let <mml:math id="jats-math-31" display="inline"><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:math> and <mml:math id="jats-math-32" display="inline"><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:math> be the underlying true DLT occurring time and true DP occurring time for the <italic toggle="yes">i</italic>th patient assigned to dose <italic toggle="yes">k</italic>. Let <mml:math id="jats-math-33" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:math>, to circumvent the missing data problem caused by semi‐competing risks and late‐onset, we propose to approximate the probability <mml:math id="jats-math-34" display="inline"><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math> as:<disp-formula id="pst2209-disp-0002"><label>(2)</label><mml:math id="jats-math-35" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>≈</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Tk</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Tk</mml:mi></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>≈</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>This approximation assumes that the time‐to‐toxicity outcome is uniformly distributed over the entire follow‐up period <mml:math id="jats-math-36" display="inline"><mml:mfenced open="[" close="]" separators=","><mml:mn>0</mml:mn><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mfenced></mml:math>. According to previous studies,<xref rid="pst2209-bib-0022" ref-type="bibr"><sup>22</sup></xref> this uniform scheme is remarkably robust and yields desirable operating characteristics. Let <mml:math id="jats-math-37" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>∣</mml:mo><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:math> and <mml:math id="jats-math-38" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>∣</mml:mo><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:math>, along the same line, we further approximate the probabilities <mml:math id="jats-math-39" display="inline"><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:math> and <mml:math id="jats-math-40" display="inline"><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:math> as:<disp-formula id="pst2209-disp-0003"><label>(3)</label><mml:math id="jats-math-41" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>≈</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>≈</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>Let us define <mml:math id="jats-math-42" display="inline"><mml:msub><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math>, <mml:math id="jats-math-43" display="inline"><mml:msub><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math>, <mml:math id="jats-math-44" display="inline"><mml:msub><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math> and <mml:math id="jats-math-45" display="inline"><mml:msub><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math>. After some algebra, we have the following expressions:<disp-formula id="pst2209-disp-0004"><mml:math id="jats-math-46" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≈</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mfrac><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Tk</mml:mi></mml:msub><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≈</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≈</mml:mo><mml:msup><mml:mfenced open="{" close="}"><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:msup><mml:msup><mml:mfenced open="{" close="}"><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi mathvariant="italic">Tki</mml:mi></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≈</mml:mo><mml:msup><mml:mfenced open="{" close="}"><mml:mrow><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:msup><mml:msup><mml:mfenced open="{" close="}"><mml:mrow><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi mathvariant="italic">Pki</mml:mi></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi mathvariant="italic">Tki</mml:mi></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Tk</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where <mml:math id="jats-math-47" display="inline"><mml:mi>I</mml:mi><mml:mfenced open="(" close=")"/></mml:math> is the indicator function. We denote <mml:math id="jats-math-48" display="inline"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math> if <mml:math id="jats-math-49" display="inline"><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math>, 0 otherwise; <mml:math id="jats-math-50" display="inline"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math> if <mml:math id="jats-math-51" display="inline"><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math>, 0 otherwise; <mml:math id="jats-math-52" display="inline"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math> if <mml:math id="jats-math-53" display="inline"><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mspace width="0.25em"/><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math>, 0 otherwise; <mml:math id="jats-math-54" display="inline"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math> if <mml:math id="jats-math-55" display="inline"><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math>, 0 otherwise. Hence, the complete likelihood function in the presence of late‐onset semi‐competing risks outcomes can be expressed as<disp-formula id="pst2209-disp-0005"><label>(4)</label><mml:math id="jats-math-56" display="block"><mml:msub><mml:mi>L</mml:mi><mml:mi mathvariant="italic">lo</mml:mi></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>K</mml:mi></mml:munderover><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:msubsup><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:msubsup><mml:msubsup><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:msubsup><mml:msubsup><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:msubsup><mml:msubsup><mml:mi mathvariant="normal">Φ</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:msubsup><mml:mo>.</mml:mo></mml:math></disp-formula>We develop a data augmentation method to derive the posterior distributions of the parameters <mml:math id="jats-math-57" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math>, <mml:math id="jats-math-58" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> and <mml:math id="jats-math-59" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> based on the likelihood function (<xref rid="pst2209-disp-0005" ref-type="disp-formula">4</xref>). We assign <mml:math id="jats-math-60" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math>, <mml:math id="jats-math-61" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> and <mml:math id="jats-math-62" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> the following Beta prior distributions:<disp-formula id="pst2209-disp-0006"><mml:math id="jats-math-63" display="block"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:msub><mml:mi>α</mml:mi><mml:mi>q</mml:mi></mml:msub><mml:msub><mml:mi>β</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mfenced><mml:mo>;</mml:mo><mml:mspace width="0.5em"/><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:msub><mml:mi>α</mml:mi><mml:mi>τ</mml:mi></mml:msub><mml:msub><mml:mi>β</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mfenced><mml:mo>;</mml:mo><mml:mspace width="0.5em"/><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:msub><mml:mi>α</mml:mi><mml:mi>τ</mml:mi></mml:msub><mml:msub><mml:mi>β</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mfenced><mml:mo>.</mml:mo></mml:math></disp-formula>Then, we use <mml:math id="jats-math-64" display="inline"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:math> to denote the missing value of <mml:math id="jats-math-65" display="inline"><mml:mi mathvariant="normal">I</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:math>. The data augmentation method is summarized as follows:</p>
              <p>1. Impute <mml:math id="jats-math-66" display="inline"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:math> from the Bernoulli distribution as<disp-formula id="pst2209-disp-0007"><mml:math id="jats-math-67" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mi>Ber</mml:mi><mml:mfenced open="(" close=")"><mml:mfrac><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mfenced><mml:mspace width="0.5em"/><mml:mtext>if</mml:mtext><mml:mspace width="0.5em"/><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>;</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mi mathvariant="italic">Ber</mml:mi><mml:mfenced open="(" close=")"><mml:mfrac><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mfenced><mml:mspace width="0.5em"/><mml:mtext>if</mml:mtext><mml:mspace width="0.5em"/><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
</p>
              <p>2. Given all the imputed data, sequentially draw the posterior samples of <mml:math id="jats-math-68" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math>, <mml:math id="jats-math-69" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> and <mml:math id="jats-math-70" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> from the Beta distributions as<disp-formula id="pst2209-disp-0008"><mml:math id="jats-math-71" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfenced open="{" close="}"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfenced open="{" close="}"><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi mathvariant="italic">Pki</mml:mi></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfenced open="{" close="}"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi mathvariant="italic">Pki</mml:mi></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mfrac><mml:mfenced open="{" close="}"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>The derivation of the data augmentation method is given in <xref rid="pst2209-app-0001" ref-type="app">Appendix</xref>. With <mml:math id="jats-math-72" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math>, <mml:math id="jats-math-73" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> and <mml:math id="jats-math-74" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math>, we can easily calculate the posterior distributions of the joint probability <mml:math id="jats-math-75" display="inline"><mml:msub><mml:mi>π</mml:mi><mml:mi mathvariant="italic">lsk</mml:mi></mml:msub></mml:math>, which will be used in the following dose‐finding design.</p>
            </sec>
            <sec id="pst2209-sec-0003">
              <label>3</label>
              <title>UTILITY FOR RISK–BENEFIT TRADEOFF</title>
              <p>The goal of a phase I/II trial is to identify the OBD, which yields the best risk–benefit tradeoff among all the candidate doses. There are various ways to define the OBD (e.g., marginal probabilities, tradeoff contour, utility function), and the utility function is arguably the most convenient and popular one, which maps the multidimensional outcomes into a single index to measure the desirability of a dose in terms of risk–benefit tradeoff. The utility function has been used in a variety of phase I/II designs to define the OBD.<xref rid="pst2209-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="pst2209-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="pst2209-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="pst2209-bib-0020" ref-type="bibr"><sup>20</sup></xref>, <xref rid="pst2209-bib-0021" ref-type="bibr"><sup>21</sup></xref>, <xref rid="pst2209-bib-0023" ref-type="bibr"><sup>23</sup></xref>, <xref rid="pst2209-bib-0024" ref-type="bibr"><sup>24</sup></xref>, <xref rid="pst2209-bib-0025" ref-type="bibr"><sup>25</sup></xref>, <xref rid="pst2209-bib-0026" ref-type="bibr"><sup>26</sup></xref> Moreover, the utility function‐based definition is flexible and incorporates other definitions as special cases.<xref rid="pst2209-bib-0016" ref-type="bibr"><sup>16</sup></xref> We use the utility function‐based definition in this paper.</p>
              <p>To construct the utility function we need to elicit from physicians the utility values <mml:math id="jats-math-76" display="inline"><mml:msub><mml:mi>ζ</mml:mi><mml:mi mathvariant="italic">ls</mml:mi></mml:msub></mml:math> associated with the probabilities <mml:math id="jats-math-77" display="inline"><mml:msub><mml:mi>π</mml:mi><mml:mi mathvariant="italic">lsk</mml:mi></mml:msub></mml:math> for <mml:math id="jats-math-78" display="inline"><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:math>. The requirement for the utility values is <mml:math id="jats-math-79" display="inline"><mml:msub><mml:mi>ζ</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>01</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>00</mml:mn></mml:msub></mml:math> because no adverse event happening is most desirable and experiencing both DLT and DP is least desirable. Constructing the utilities requires close collaboration between clinicians and statisticians and should be customized to reflect the clinical needs and practice best. In our experience, the process of elicitation of utility values is quite natural. It can be done by simply explaining what the utilities represent to the clinicians during the decision process and asking them to specify all values after fixing the ones for the worst and best outcome. In particular, we can first fix two boundaries as <mml:math id="jats-math-80" display="inline"><mml:msub><mml:mi>ζ</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math> and <mml:math id="jats-math-81" display="inline"><mml:msub><mml:mi>ζ</mml:mi><mml:mn>00</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>100</mml:mn></mml:math>
<sub>,</sub> and then elicit the utility values for the remaining ones by using the two boundaries as a reference, which must be located between 0 and 100. After eliciting the utility values, the utility function for dose level <mml:math id="jats-math-82" display="inline"><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:math> can be constructed as<disp-formula id="pst2209-disp-0009"><mml:math id="jats-math-83" display="block"><mml:mi mathvariant="normal">U</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mn>1</mml:mn></mml:munderover><mml:msub><mml:mi>ζ</mml:mi><mml:mi mathvariant="italic">ls</mml:mi></mml:msub><mml:msub><mml:mi>π</mml:mi><mml:mi mathvariant="italic">lsk</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:math></disp-formula>During the trial, given the interim data <mml:math id="jats-math-84" display="inline"><mml:mi mathvariant="script">D</mml:mi></mml:math>, we can calculate the posterior mean utility as<disp-formula id="pst2209-disp-0010"><mml:math id="jats-math-85" display="block"><mml:mover accent="true"><mml:mi>U</mml:mi><mml:mo stretchy="true">˜</mml:mo></mml:mover><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:mi mathvariant="script">D</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo>∫</mml:mo><mml:mi>U</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced><mml:mi>f</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mi mathvariant="script">D</mml:mi></mml:mfenced><mml:mi>d</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:math></disp-formula>In addition to <mml:math id="jats-math-86" display="inline"><mml:mover accent="true"><mml:mi>U</mml:mi><mml:mo stretchy="true">˜</mml:mo></mml:mover><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:mi mathvariant="script">D</mml:mi></mml:mfenced></mml:math>, we also need to construct an admissible set to safeguard patients from overly toxic and less efficacious doses. We define <mml:math id="jats-math-87" display="inline"><mml:msub><mml:mi>ε</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:math> as the maximum tolerable DLT rate and <mml:math id="jats-math-88" display="inline"><mml:msub><mml:mi>ε</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:math> as the maximum tolerable DP rate. We first define the admissible set of toxicity as<disp-formula id="pst2209-disp-0011"><mml:math id="jats-math-89" display="block"><mml:msub><mml:mi mathvariant="script">A</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfenced open="{" close="}"><mml:mrow><mml:mi>k</mml:mi><mml:mo>:</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo>∩</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>ε</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow><mml:mi mathvariant="script">D</mml:mi></mml:mfenced><mml:mo>≤</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>∩</mml:mo><mml:mi>⋯</mml:mi><mml:mo>∩</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>ε</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow><mml:mi mathvariant="script">D</mml:mi></mml:mfenced><mml:mo>≤</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math></disp-formula>If any dose <mml:math id="jats-math-90" display="inline"><mml:mi>k</mml:mi></mml:math> is found to be overly toxic during the interim analysis, then all the doses no less than <mml:math id="jats-math-91" display="inline"><mml:mi>k</mml:mi></mml:math> should be excluded from the trial because the toxicity rate generally increases as the dose level increases. Then, Let <mml:math id="jats-math-92" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfenced></mml:math>, we define the admissible set as<disp-formula id="pst2209-disp-0012"><mml:math id="jats-math-93" display="block"><mml:mi mathvariant="script">A</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfenced open="{" close="}"><mml:mrow><mml:mi>k</mml:mi><mml:mo>:</mml:mo><mml:mi>k</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mi mathvariant="script">A</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>∩</mml:mo><mml:mi>Pr</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>ε</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mrow><mml:mi mathvariant="script">D</mml:mi></mml:mfenced><mml:mo>≤</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math></disp-formula>
<mml:math id="jats-math-94" display="inline"><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:math> and <mml:math id="jats-math-95" display="inline"><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:math> are cut‐off values, which can be calibrated through simulation studies. Finally, the dose that yields the highest posterior mean utility <mml:math id="jats-math-96" display="inline"><mml:mover accent="true"><mml:mi>U</mml:mi><mml:mo stretchy="true">˜</mml:mo></mml:mover><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:mi mathvariant="script">D</mml:mi></mml:mfenced></mml:math> within the admissible set <mml:math id="jats-math-97" display="inline"><mml:mi mathvariant="script">A</mml:mi></mml:math> is the identified OBD. Based on the aforementioned content, the toxicity rate <mml:math id="jats-math-98" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> will be underestimated, and risky doses may be included in the admissible set if the issue of the semi‐competing risks is ignored. In terms of the utility function, the impact of semi‐competing risks is summarized in the following theorem.<statement content-type="Theorem" id="pst2209-mthst-0001"><label>Theorem 1</label><p><italic toggle="yes">The utility function</italic><mml:math id="jats-math-99" display="inline"><mml:mi>U</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced></mml:math><italic toggle="yes">is overestimated if the issue of the semi‐competing risks is ignored</italic>.</p></statement>
</p>
              <p>The proof of Theorem <xref rid="pst2209-mthst-0001" ref-type="statement">1</xref> is given in the <xref rid="pst2209-app-0001" ref-type="app">Appendix</xref>. As the semi‐competing risks can distort both <mml:math id="jats-math-100" display="inline"><mml:mi mathvariant="script">A</mml:mi></mml:math> and <mml:math id="jats-math-101" display="inline"><mml:mi>U</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced></mml:math>, the probability model and data augmentation algorithm developed in this paper are necessary.</p>
            </sec>
            <sec id="pst2209-sec-0004">
              <label>4</label>
              <title>DOSE‐FINDING ALGORITHM</title>
              <p>We propose the following dose‐finding algorithm to find the OBD for a phase I/II trial with the utility function and admissible set constructed.</p>
              <p><list list-type="order" id="pst2209-list-0008"><list-item id="pst2209-li-0031"><p>The first cohort of patients is treated at the lowest dose level or another physician‐specified dose level.</p></list-item><list-item id="pst2209-li-0032"><p>Update the posterior distribution of all the parameters of interest at the current dose level.</p></list-item><list-item id="pst2209-li-0033"><p>Use the updated posterior distribution to construct the admissible set and identify the OBD. If the admissible set is empty, early terminate the trial and conclude that no dose can be selected as the OBD.</p></list-item><list-item id="pst2209-li-0034"><p>Treat the next cohort of patients at the identified OBD.</p></list-item><list-item id="pst2209-li-0035"><p>Repeat steps 1–4 until the maximum sample size is reached. Dose skipping is not allowed when a dose‐escalation occurs.</p></list-item></list>The proposed probability model does not model the untried dose. As a result, the dose‐finding procedure is restricted to tired doses and may miss the global optimal dose. To solve this problem, we propose an additional dose‐escalation rule. Specifically, let <mml:math id="jats-math-102" display="inline"><mml:msup><mml:mi>k</mml:mi><mml:mo>*</mml:mo></mml:msup></mml:math> be the highest dose that has been tired so far. If during any dose‐finding step, we have <mml:math id="jats-math-103" display="inline"><mml:msup><mml:mi>k</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>∈</mml:mo><mml:msub><mml:mi mathvariant="script">A</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:math>, indicating that the true OBD may be greater than <mml:math id="jats-math-104" display="inline"><mml:msup><mml:mi>k</mml:mi><mml:mo>*</mml:mo></mml:msup></mml:math>, we will do the dose‐escalation and allocate the next cohort of patients at dose level <mml:math id="jats-math-105" display="inline"><mml:msup><mml:mi>k</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:math> if it is possible to further explore the dose–response profiles. Once the trial ends, we select the dose with the highest posterior mean utility within the admissible set as the recommended OBD.</p>
            </sec>
            <sec id="pst2209-sec-0005">
              <label>5</label>
              <title>TRIAL APPLICATION</title>
              <p>As an essential step to apply the proposed design to the motivating AML trial, we first evaluate the operating characteristics of the proposed design. Reporting operating characteristics is often required in trial protocols when a new design is involved. We considered a phase I/II trial with five doses and a maximum sample size of 60 in cohorts of size 3. We specified a DP upper bound <mml:math id="jats-math-106" display="inline"><mml:msub><mml:mi>ε</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:math> with a cut‐off value <mml:math id="jats-math-107" display="inline"><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0.9</mml:mn></mml:math>, a DLT upper bound of <mml:math id="jats-math-108" display="inline"><mml:msub><mml:mi>ε</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0.3</mml:mn></mml:math> with a cut‐off value <mml:math id="jats-math-109" display="inline"><mml:msub><mml:mi>C</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0.95</mml:mn></mml:math>. We elicited the utility values as <mml:math id="jats-math-110" display="inline"><mml:msub><mml:mi>ζ</mml:mi><mml:mn>00</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>100</mml:mn></mml:math>, <mml:math id="jats-math-111" display="inline"><mml:msub><mml:mi>ζ</mml:mi><mml:mn>01</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>50</mml:mn></mml:math>, <mml:math id="jats-math-112" display="inline"><mml:msub><mml:mi>ζ</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>25</mml:mn></mml:math> and <mml:math id="jats-math-113" display="inline"><mml:msub><mml:mi>ζ</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math>. We specify independent non‐informative beta priors <mml:math id="jats-math-114" display="inline"><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")"><mml:mn>0.5,0.5</mml:mn></mml:mfenced></mml:math> for <mml:math id="jats-math-115" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math>, <mml:math id="jats-math-116" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> and <mml:math id="jats-math-117" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math>. Table <xref rid="pst2209-tbl-0001" ref-type="table">1</xref> shows the simulation results with different dose–response curves, including the OBD selection probability, the average number of patients treated at each dose level, the average percentages of patients experiencing DP, DLT, the average sample size <mml:math id="jats-math-118" display="inline"><mml:mi>N</mml:mi></mml:math> and the average trial duration across 5000 simulated trials. A boldface font emphasizes the result for the true OBD. We specify a fixed total follow‐up time of 2 months for every patient and an inter‐arrival time <mml:math id="jats-math-119" display="inline"><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math> month. A new cohort of patients will enter the trial every month. We first simulate the time‐to‐DLT outcome from a Weibull distribution to generate the survival outcomes. Then, we simulate two independent time‐to‐DP outcomes conditional on <mml:math id="jats-math-120" display="inline"><mml:msub><mml:mi>Y</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math> or 1, also from the Weibull distributions. The parameters in the Weibull distributions are calibrated to match the pre‐specified response rates. We compare the proposed SCI design with two alternatives. The first one uses the observable data only during the interim analysis, and we name it the observed‐data design. Any patients with missing DP or DLT are ignored under the observed‐data design. The second one suspends the trial during the interim analysis in the presence of late‐onset outcome and reopens the trial until all the patients have been completely followed, and we name it the complete‐data design. In scenario 1, none of the doses is acceptable due to overly toxic or less efficacious. All the designs under comparison yield almost surely probabilities of terminating the trial early with no dose selected. When the true OBD does exist (scenarios 2–6), as we expect, the complete‐data design always yields the best performances in terms of OBD selection and patient allocation because of the fully observable data being used. However, compared with the SCI and observed‐data designs, the complete‐data design doubles the trial duration when the true OBD exists, making the design impractical. It is also highly unethical to frequently suspend the trial and let the patients already in the trial wait until all the data become observable. The SCI design outperforms the observed‐data design across all the scenarios under consideration, and the difference can be substantial. For example, under scenario 2, the true OBD selection rate for the SCI design is 49.3%, which is about 18% higher than that for the observed‐data design. Also, the number of patients at the OBD for the SCI design is 8.5 higher than the number for the observed‐data design. The results for scenarios 3–6 are similar.</p>
              <table-wrap position="float" id="pst2209-tbl-0001" content-type="TABLE">
                <label>TABLE 1</label>
                <caption>
                  <p>Operating characteristics of the SCI, observed‐data, and complete‐data designs based on 5000 replicates</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="char" char="." span="1"/>
                  <col align="char" char="." span="1"/>
                  <col align="char" char="." span="1"/>
                  <col align="char" char="." span="1"/>
                  <col align="char" char="." span="1"/>
                  <col align="char" char="." span="1"/>
                  <col align="char" char="." span="1"/>
                  <col align="char" char="." span="1"/>
                  <col align="char" char="." span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000">
                      <th style="border-bottom:solid 1px #000000" align="left" colspan="2" rowspan="2" valign="bottom">Design</th>
                      <th align="left" style="border-bottom:solid 1px #000000" colspan="6" valign="bottom" rowspan="1">Dose level</th>
                      <th align="left" style="border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">DLT/DP (%)</th>
                      <th align="left" style="border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">
                        <italic toggle="yes">N</italic>
                      </th>
                      <th align="left" style="border-bottom:solid 1px #000000" rowspan="2" valign="bottom" colspan="1">Duration (month)</th>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">1</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">2</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">3</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">4</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">5</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">None</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Scenario 1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.95,0.25)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.9,0.4)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.85,0.5)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.45,0.7)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.4,0.75)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Utility</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">22.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">38.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">39.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">SCI</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>99.6</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">4.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">2.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">46.9/77.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">27.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.1</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Observed data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>99.4</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">53.3/69.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">33.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.1</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Complete data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>99.7</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">3.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">3.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">3.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">2.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">51.3/71.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">18.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.5</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Scenario 2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.35,0.03)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.32,0.25)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.3,0.28)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.28,0.35)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.28,0.4)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Utility</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">72.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">64.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">64.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">63.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">61.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">SCI</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>49.3</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">15.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">4.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>23.7</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">10.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">19.4/31.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.0</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Observed data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>31.4</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">23.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">19.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">15.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>15.2</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">24.3/30.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.0</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Complete data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>50.1</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">18.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">14.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">4.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>23.0</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">20.3/31.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">39.8</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Scenario 3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.45,0.05)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.25,0.08)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.23,0.27)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.2,0.4)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.2,0.5)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Utility</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">64.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">77.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">70.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">66.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">61.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">SCI</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">17.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>50.9</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">22.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">1.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>23.6</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">4.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">18.8/27.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">20.9</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Observed data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">18.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>39.1</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">30.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">10.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">1.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">10.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>17.6</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">15.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">22.4/26.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.0</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Complete data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>57.3</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">1.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>25.6</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">4.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">19.0/26.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">39.8</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Scenario 4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.7,0.1)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.45,0.2)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.3,0.22)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.4,0.28)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.45,0.4)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Utility</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">43.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">57.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">67.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">58.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">49.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">SCI</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">1.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">22.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>48.5</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">18.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">3.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">13.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>21.4</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">23.1/41.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">57.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">20.2</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Observed data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>43.7</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">24.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">2.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">4.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>20.9</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">14.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">24.2/40.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">20.7</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Complete data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">1.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">19.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>53.4</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">17.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">3.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>24.9</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">23.4/39.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">57.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">38.6</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Scenario 5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.6,0.05)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.48,0.1)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.45,0.12)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.2,0.15)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.35,0.25)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Utility</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">53.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">61.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">78.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">62.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">SCI</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">4.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>57.7</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>25.3</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">14.0/35.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">20.9</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Observed data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">4.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">13.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">17.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>43.2</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">6.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">10.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>21.3</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">12.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">14.7/35.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.0</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Complete data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">2.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>69.6</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">10.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">5.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>30.5</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">14.6/32.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">39.8</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Scenario 6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.45,0.1)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.4,0.15)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.35,0.2)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.3,0.23)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">(0.1,0.25)</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1">Utility</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">62.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">63.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">64.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">67.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">80.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">SCI</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">13.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">14.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">15.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>43.9</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">1.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">10.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">10.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>19.7</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">19.7/28.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">20.8</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Observed‐data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">13.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">16.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">18.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">19.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>32.9</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">10.3</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.6</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>18.0</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">20.0/28.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">21.0</td>
                    </tr>
                    <tr>
                      <td rowspan="2" align="left" valign="top" colspan="1">Complete‐data</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">% Selected</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.8</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">9.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">11.4</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>60.2</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1">0.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"># Patients</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.2</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.1</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">7.9</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">8.5</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">
                        <bold>27.0</bold>
                      </td>
                      <td align="char" valign="top" rowspan="1" colspan="1"/>
                      <td align="char" valign="top" rowspan="1" colspan="1">20.7/25.0</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">59.7</td>
                      <td align="char" valign="top" rowspan="1" colspan="1">39.8</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="pst2209-ntgp-0001">
                  <fn id="pst2209-note-0001">
                    <p><italic toggle="yes">Notes</italic>: The probability pairs in parentheses are the probabilities of DP occurring and DLT occurring for each dose level. The percentage of trials with no dose selected is denoted by “None.” DLT/DP (%) is the percentage of patients experiencing DLT and the percentage of patients experiencing DP. <italic toggle="yes">N</italic> is the total number of patients. The numbers in bold font indicate the OBD selection rates and patient allocation under the true OBD.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>We also conducted two sensitivity analyses to investigate the robustness of the proposed SCI method. In Figure <xref rid="pst2209-fig-0002" ref-type="fig">2</xref>, we report the OBD selection percentages of the observed‐data, SCI, and complete‐data designs with different data generating distributions such as the Weibull, Lognormal, and Gamma. Figure <xref rid="pst2209-fig-0003" ref-type="fig">3</xref> reports the OBD selection percentages of all three designs with different inter‐arrival times <mml:math id="jats-math-121" display="inline"><mml:mi>τ</mml:mi></mml:math>. The results show that the SCI performs robustly under different data generating distributions and inter‐arrival time <mml:math id="jats-math-122" display="inline"><mml:mi>τ</mml:mi></mml:math>. In conclusion, the pattern of the design comparison keeps consistent across all the tables and figures.</p>
              <fig position="float" fig-type="FIGURE" id="pst2209-fig-0002">
                <label>FIGURE 2</label>
                <caption>
                  <p>Sensitivity analysis with different time‐to‐event generating functions</p>
                </caption>
                <graphic xlink:href="PST-21-960-g002" position="anchor" id="jats-graphic-3"/>
              </fig>
              <fig position="float" fig-type="FIGURE" id="pst2209-fig-0003">
                <label>FIGURE 3</label>
                <caption>
                  <p>Sensitivity analysis with different <mml:math id="jats-math-123" display="inline"><mml:mi>τ</mml:mi></mml:math>
</p>
                </caption>
                <graphic xlink:href="PST-21-960-g003" position="anchor" id="jats-graphic-5"/>
              </fig>
            </sec>
            <sec sec-type="conclusions" id="pst2209-sec-0006">
              <label>6</label>
              <title>CONCLUSION</title>
              <p>We develop a phase I/II clinical trial design to identify the OBD of IT in the presence of semi‐competing risks. We propose reconstructing the likelihood based on the actual follow‐up time and developing a data augmentation method to derive the posterior distributions for the parameters of interest. Simulation results confirm the desirable performance of the proposed SCI design. The complete‐data design significantly prolongs the trial duration and should not be considered. Considering that the proposed SCI design is more complicated than the naive observed‐data design, the latter can be considered as an alternative to the SCI design in the presence of a mild late‐onset issue.</p>
              <p>The issue of semi‐competing risks has been intensively studied in the statistical community, and a lot of sophisticated survival analysis models have been proposed, such as the multi‐state model<xref rid="pst2209-bib-0027" ref-type="bibr"><sup>27</sup></xref>, <xref rid="pst2209-bib-0028" ref-type="bibr"><sup>28</sup></xref> and latent failure times model,<xref rid="pst2209-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="pst2209-bib-0029" ref-type="bibr"><sup>29</sup></xref>, <xref rid="pst2209-bib-0030" ref-type="bibr"><sup>30</sup></xref>, <xref rid="pst2209-bib-0031" ref-type="bibr"><sup>31</sup></xref> which treat the data as time‐to‐event. The benefits of treating the semi‐competing risks data as time‐to‐event and using the survival modeling approaches include incorporating the length of time into consideration, handling censored data, and estimating the hazard ratio for association studies, among others. However, the high learning cost impedes the application of these complicated models in practical trial conduct. Moreover, the performances of the survival models rely on a series of parametric model assumptions, which are hard to justify and verify for a dose‐finding trial with a limited sample size. On the other hand, the SCI design treats the censored data as missing and imputes them from the multinomial distribution for categorical data, which is more transparent and user‐friendly for the clinical community. The only model assumption for the SCI design is the uniform distribution on the censored data, which is proved to be a fair and reasonable assumption.<xref rid="pst2209-bib-0020" ref-type="bibr"><sup>20</sup></xref>, <xref rid="pst2209-bib-0022" ref-type="bibr"><sup>22</sup></xref>, <xref rid="pst2209-bib-0032" ref-type="bibr"><sup>32</sup></xref> Indeed, the censoring status is dynamically updated among different interim decision‐making times. As the trial goes on, more and more patients change their status from censoring to observed, so the uniform distribution assumption is gradually relieved and eventually removed for the final optimal dose selection. The SCI design makes no parametric assumption on the dose–response curve and toxicity‐efficacy correlation and therefore is a robust design against parametric model assumption. Another feature of the SCI design is that it provides a unified solution for both the semi‐competing and late‐onset outcomes. The proposed data augmentation method treats the censoring data due to either the semi‐competing risks or late‐onset as the same type of missing data and imputes them using one Gibbs sampling algorithm. As a result, the SCI design can be directly applied for a mixture of semi‐competing risks and/or late‐onset data.</p>
              <p>One possible extension of the SCI design is to incorporate the immune response. Immune response measures IT's biological efficacy in activating the immune system and is closely correlated with the toxicity and efficacy outcomes. By accounting for the immune response, we may further improve the performance of the SCI design. Also, IT is often used together with other drugs. Therefore, it is vital to extend the SCI design to identify the optimal dose pair for the drug–drug combination trial.</p>
            </sec>
            <sec sec-type="COI-statement" id="pst2209-sec-0008">
              <title>CONFLICT OF INTEREST</title>
              <p>The authors declare no conflict of interest.</p>
            </sec>
          </body>
          <back>
            <ack id="pst2209-sec-0007">
              <title>ACKNOWLEDGMENTS</title>
              <p>The authors thank two reviewers for their helpful comments, which improve the presentation of this paper. Yong Zang's research is partially supported by National Institutes of Health/NCI grants P30 CA082709, R21 CA264257, and the RalphW. and Grace M. Showalter Research Trust award. Beibei Guo's research is partially supported by R&amp;D Research Competitiveness Subprogram of Louisiana Board of Regents, Contract number LEQSF(2020‐21)‐RD‐A‐04. Sha Cao's research is partially supported by Indiana University Precision Health Initiative. Chi Zhang's research is partially supported by National Science Foundation DBI IIBR 2047631.</p>
            </ack>
            <sec sec-type="data-availability" id="pst2209-sec-0010">
              <title>DATA AVAILABILITY STATEMENT</title>
              <p>This is a methodological paper for clinical trial design and no real data is used. All the results are based on simulation studies. The R codes to implement the proposed research are freely available at <ext-link xlink:href="https://github.com/yongzang2020/SCI" ext-link-type="uri" specific-use="software is-supplemented-by">https://github.com/yongzang2020/SCI</ext-link>.</p>
            </sec>
            <ref-list id="pst2209-bibl-0001" content-type="cited-references">
              <title>REFERENCES</title>
              <ref id="pst2209-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0001"><string-name><surname>Syn</surname><given-names>NL</given-names></string-name>, <string-name><surname>Teng</surname><given-names>MWL</given-names></string-name>, <string-name><surname>Mok</surname><given-names>TSK</given-names></string-name>, <string-name><surname>Soo</surname><given-names>RA</given-names></string-name>. <article-title>De‐novo and acquired resistance to immune checkpoint targeting</article-title>. <source>Lancet Oncol</source>. <year>2017</year>;<volume>18</volume>:<fpage>731</fpage>‐<lpage>741</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0002"><string-name><surname>Topalian</surname><given-names>SL</given-names></string-name>, <string-name><surname>Weiner</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Pardoll</surname><given-names>DM</given-names></string-name>. <article-title>Cancer immunotherapy comes of age</article-title>. <source>J Clin Oncol</source>. <year>2011</year>;<volume>23</volume>:<fpage>4828</fpage>‐<lpage>4836</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0003"><string-name><surname>Makkouk</surname><given-names>A</given-names></string-name>, <string-name><surname>Weiner</surname><given-names>GJ</given-names></string-name>. <article-title>Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge</article-title>. <source>Cancer Res</source>. <year>2015</year>;<volume>75</volume>:<fpage>5</fpage>‐<lpage>10</lpage>.<pub-id pub-id-type="pmid">25524899</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0004"><string-name><surname>Couzin‐Frankel</surname><given-names>J</given-names></string-name>. <article-title>Cancer immunotherapy</article-title>. <source>Science</source>. <year>2013</year>;<volume>324</volume>:<fpage>1432</fpage>‐<lpage>1433</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0005"><string-name><surname>Khalil</surname><given-names>DN</given-names></string-name>, <string-name><surname>Smith</surname><given-names>EL</given-names></string-name>, <string-name><surname>Brentjens</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Wolchok</surname><given-names>JD</given-names></string-name>. <article-title>The future of cancer treatment: immunomodulation, CARs and combination immunotherapy</article-title>. <source>Nat Rev Clin Oncol</source>. <year>2016</year>;<volume>13</volume>:<fpage>273</fpage>‐<lpage>290</lpage>.<pub-id pub-id-type="pmid">26977780</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="book" id="pst2209-cit-0006"><string-name><surname>Yuan</surname><given-names>Y</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>HQ</given-names></string-name>, <string-name><surname>Thall</surname><given-names>PF</given-names></string-name>. <source>Bayesian designs for phase I–II clinical trials</source>. <publisher-name>Chapman &amp; Hall</publisher-name>; <year>2016</year>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0007"><string-name><surname>Borcoman</surname><given-names>E</given-names></string-name>, <string-name><surname>Kanjanapan</surname><given-names>Y</given-names></string-name>, <string-name><surname>Champiat</surname><given-names>S</given-names></string-name>, et al. <article-title>Novel patterns of response under immunotherapy</article-title>. <source>Ann Oncol</source>. <year>2019</year>;<volume>30</volume>:<fpage>385</fpage>‐<lpage>396</lpage>.<pub-id pub-id-type="pmid">30657859</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0008"><string-name><surname>Fine</surname><given-names>JP</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>H</given-names></string-name>, <string-name><surname>Chappell</surname><given-names>R</given-names></string-name>. <article-title>On semi‐competing risks data</article-title>. <source>Biometrika</source>. <year>2001</year>;<volume>88</volume>:<fpage>907</fpage>‐<lpage>919</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0009"><string-name><surname>Yuan</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yin</surname><given-names>G</given-names></string-name>. <article-title>Robust EM continual reassessment method in oncology dose‐finding</article-title>. <source>J Am Stat Assoc</source>. <year>2011</year>;<volume>106</volume>:<fpage>818</fpage>‐<lpage>831</lpage>.<pub-id pub-id-type="pmid">22375092</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0010"><string-name><surname>Tanner</surname><given-names>MA</given-names></string-name>, <string-name><surname>Wong</surname><given-names>WH</given-names></string-name>. <article-title>The calculation of posterior distributions by data augmentation</article-title>. <source>J Am Stat Assoc</source>. <year>1987</year>;<volume>82</volume>:<fpage>528</fpage>‐<lpage>550</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0011"><string-name><surname>Francisco</surname><given-names>LM</given-names></string-name>, <string-name><surname>Sage</surname><given-names>PT</given-names></string-name>, <string-name><surname>Sharpe</surname><given-names>AH</given-names></string-name>. <article-title>The PD‐1 pathway in tolerance and autoimmunity</article-title>. <source>Immunol Rev</source>. <year>2010</year>;<volume>236</volume>:<fpage>219</fpage>‐<lpage>242</lpage>.<pub-id pub-id-type="pmid">20636820</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0012"><string-name><surname>Messer</surname><given-names>K</given-names></string-name>, <string-name><surname>Natarajan</surname><given-names>L</given-names></string-name>, <string-name><surname>Ball</surname><given-names>ED</given-names></string-name>, <string-name><surname>Lane</surname><given-names>TA</given-names></string-name>. <article-title>Toxicity‐evaluation designs for phase I/II cancer immunotherapy trials</article-title>. <source>Sat Med</source>. <year>2010</year>;<volume>29</volume>:<fpage>712</fpage>‐<lpage>720</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0013"><string-name><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>VE</given-names></string-name>. <article-title>A robust Bayesian dose‐finding design for phase I/II clincial trials</article-title>. <source>Biostatistics</source>. <year>2016</year>;<volume>17</volume>:<fpage>249</fpage>‐<lpage>263</lpage>.<pub-id pub-id-type="pmid">26486139</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0014"><string-name><surname>Lin</surname><given-names>R</given-names></string-name>, <string-name><surname>Yin</surname><given-names>G</given-names></string-name>. <article-title>STEIN: a simple toxicity and efficacy interval design for seamless phase I/II clinical trials</article-title>. <source>Stat Med</source>. <year>2017</year>;<volume>36</volume>:<fpage>4106</fpage>‐<lpage>4120</lpage>.<pub-id pub-id-type="pmid">28786138</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0015"><string-name><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name><surname>Guo</surname><given-names>B</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y</given-names></string-name>. <article-title>A Bayesian phase I/II design for immunotherapy trials</article-title>. <source>J Am Stat Assoc</source>. <year>2018</year>;<volume>113</volume>:<fpage>1016</fpage>‐<lpage>1027</lpage>.<pub-id pub-id-type="pmid">31741544</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0016"><string-name><surname>Zhou</surname><given-names>Y</given-names></string-name>, <string-name><surname>Lee</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y</given-names></string-name>. <article-title>A utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies</article-title>. <source>Stat Med</source>. <year>2019</year>;<volume>38</volume>:<fpage>5299</fpage>‐<lpage>5316</lpage>.<pub-id pub-id-type="pmid">31621952</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0017"><string-name><surname>Han</surname><given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H</given-names></string-name>, <string-name><surname>Cao</surname><given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C</given-names></string-name>, <string-name><surname>Zang</surname><given-names>Y</given-names></string-name>. <article-title>TSNP: a two‐stage nonparametric phase I/II clinical trial design for immunotherapy</article-title>. <source>Pharm Stat</source>. <year>2020</year>;<volume>20</volume>(<issue>2</issue>):<fpage>282</fpage>‐<lpage>296</lpage>.<pub-id pub-id-type="pmid">33025762</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0018"><string-name><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name><surname>Yin</surname><given-names>G</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y</given-names></string-name>. <article-title>Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity</article-title>. <source>Ann Appl Stat</source>. <year>2013</year>;<volume>7</volume>:<fpage>1837</fpage>‐<lpage>2457</lpage>.<pub-id pub-id-type="pmid">24707327</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0019"><string-name><surname>Jin</surname><given-names>IH</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name><surname>Thall</surname><given-names>P</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y</given-names></string-name>. <article-title>Using data augmentation to facilitate conduct of phase I/II clinical trials with delayed outcomes</article-title>. <source>J Am Stat Assoc</source>. <year>2014</year>;<volume>109</volume>:<fpage>525</fpage>‐<lpage>536</lpage>.<pub-id pub-id-type="pmid">25382884</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0020"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zang</surname><given-names>Y</given-names></string-name>. <article-title>CWL: a conditional weighted likelihood method to account for the delayed joint toxicity‐efficacy outcomes for phase I/II clinical trials</article-title>. <source>Stat Method Med Res</source>. <year>2021</year>;<volume>30</volume>:<fpage>892</fpage>‐<lpage>903</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0021"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Cao</surname><given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C</given-names></string-name>, <string-name><surname>Jin</surname><given-names>IH</given-names></string-name>, <string-name><surname>Zang</surname><given-names>Y</given-names></string-name>. <article-title>A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes</article-title>. <source>Biometrics</source>. <year>2021</year>;<volume>77</volume>:<fpage>796</fpage>‐<lpage>808</lpage>.<pub-id pub-id-type="pmid">32735346</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0022"><string-name><surname>Cheung</surname><given-names>YK</given-names></string-name>, <string-name><surname>Chappell</surname><given-names>R</given-names></string-name>. <article-title>Sequential designs for phase I clinical trials with late‐onset toxicities</article-title>. <source>Biometrics</source>. <year>2000</year>;<volume>56</volume>:<fpage>1177</fpage>‐<lpage>1182</lpage>.<pub-id pub-id-type="pmid">11129476</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0023"><string-name><surname>Houede</surname><given-names>N</given-names></string-name>, <string-name><surname>Thall</surname><given-names>PF</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>H</given-names></string-name>, <string-name><surname>Paoletti</surname><given-names>X</given-names></string-name>, <string-name><surname>Kramar</surname><given-names>A</given-names></string-name>. <article-title>Utility‐based optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trials</article-title>. <source>Biometrics</source>. <year>2010</year>;<volume>66</volume>:<fpage>532</fpage>‐<lpage>540</lpage>.<pub-id pub-id-type="pmid">19673865</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0024"><string-name><surname>Thall</surname><given-names>PF</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>HQ</given-names></string-name>, <string-name><surname>Braun</surname><given-names>TM</given-names></string-name>, <string-name><surname>Qazilbash</surname><given-names>MH</given-names></string-name>. <article-title>Using joint utilities of the times to response and toxicity to adaptively optimize schedule‐dose regimes</article-title>. <source>Biometrics</source>. <year>2013</year>;<volume>69</volume>:<fpage>673</fpage>‐<lpage>682</lpage>.<pub-id pub-id-type="pmid">23957592</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0025"><string-name><surname>Thall</surname><given-names>PF</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>HQ</given-names></string-name>, <string-name><surname>Zohar</surname><given-names>S</given-names></string-name>, <string-name><surname>Maton</surname><given-names>P</given-names></string-name>. <article-title>Optimizing sedative dose in preterm infants undergoing treatment for respiratory distress syndrome</article-title>. <source>J Am Stat Assoc</source>. <year>2014</year>;<volume>109</volume>:<fpage>931</fpage>‐<lpage>943</lpage>.<pub-id pub-id-type="pmid">25368435</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0026"><string-name><surname>Murray</surname><given-names>TA</given-names></string-name>, <string-name><surname>Thall</surname><given-names>PF</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y</given-names></string-name>, <string-name><surname>McAvoy</surname><given-names>S</given-names></string-name>, <string-name><surname>Gomez</surname><given-names>DR</given-names></string-name>. <article-title>Robust treatment comparison based on utilities of semi‐competing risks in non‐small‐cell lung cancer</article-title>. <source>J Am Stat Assoc</source>. <year>2017</year>;<volume>112</volume>:<fpage>11</fpage>‐<lpage>23</lpage>.<pub-id pub-id-type="pmid">28943681</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0027"><string-name><surname>Fix</surname><given-names>E</given-names></string-name>, <string-name><surname>Neyman</surname><given-names>J</given-names></string-name>. <article-title>A simple stochastic model of recovery, relapse, death and loss of patients</article-title>. <source>Hum Biol 1951</source>. <year>1951</year>;<volume>23</volume>(<issue>3</issue>):<fpage>205</fpage>‐<lpage>241</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0028"><string-name><surname>Hougaard</surname><given-names>P</given-names></string-name>. <article-title>Multi‐state models: a review</article-title>. <source>Lifetime Data Anal</source>. <year>1999</year>;<volume>5</volume>:<fpage>239</fpage>‐<lpage>264</lpage>.<pub-id pub-id-type="pmid">10518372</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0029"><string-name><surname>Peng</surname><given-names>L</given-names></string-name>, <string-name><surname>Fine</surname><given-names>JP</given-names></string-name>. <article-title>Rank estimation of accelerated lifetime models with dependent censoring</article-title>. <source>J Am Stat Assoc</source>. <year>2006</year>;<volume>101</volume>:<fpage>1085</fpage>‐<lpage>1093</lpage>.</mixed-citation>
              </ref>
              <ref id="pst2209-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0030"><string-name><surname>Peng</surname><given-names>L</given-names></string-name>, <string-name><surname>Fine</surname><given-names>JP</given-names></string-name>. <article-title>Regression modeling of semicompeting risks data</article-title>. <source>Biometrics</source>. <year>2007</year>;<volume>63</volume>:<fpage>96</fpage>‐<lpage>108</lpage>.<pub-id pub-id-type="pmid">17447934</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0031"><string-name><surname>Hsieh</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Huang</surname><given-names>YT</given-names></string-name>. <article-title>Regression analysis based on conditional likelihood approach under semi‐competing risks data</article-title>. <source>Lifetime Data Anal</source>. <year>2012</year>;<volume>18</volume>:<fpage>302</fpage>‐<lpage>320</lpage>.<pub-id pub-id-type="pmid">22407536</pub-id></mixed-citation>
              </ref>
              <ref id="pst2209-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="pst2209-cit-0032"><string-name><surname>Lin</surname><given-names>R</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y</given-names></string-name>. <article-title>Time‐to‐event model‐assisted designs for dose‐finding trials with delayed toxicity</article-title>. <source>Biostatistics</source>. <year>2020</year>;<volume>21</volume>:<fpage>807</fpage>‐<lpage>824</lpage>.<pub-id pub-id-type="pmid">30984972</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <app-group>
              <app id="pst2209-app-0001" content-type="APPENDIX">
                <label>APPENDIX A</label>
                <sec id="pst2209-sec-0011">
                  <title>Derivation of the data augmentation method in the presence of late‐onset</title>
                  <p>The likelihood function for <mml:math id="jats-math-124" display="inline"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:math> can be written as,<disp-formula id="pst2209-disp-0013"><mml:math id="jats-math-125" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mi>L</mml:mi><mml:mi>ω</mml:mi></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:msup><mml:mfenced open="[" close="]"><mml:mrow><mml:msup><mml:mfenced open="{" close="}"><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:msup><mml:msup><mml:mfenced open="{" close="}"><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfenced><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msup><mml:mfenced open="[" close="]"><mml:mrow><mml:msup><mml:mfenced open="{" close="}"><mml:mrow><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:msup><mml:msup><mml:mfenced open="{" close="}"><mml:mrow><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:mfenced><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:msup><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
</p>
                  <p>Hence, if <mml:math id="jats-math-126" display="inline"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math>, <mml:math id="jats-math-127" display="inline"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:math> should be imputed as,<disp-formula id="pst2209-disp-0014"><mml:math id="jats-math-128" display="block"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mi>Ber</mml:mi><mml:mfenced open="(" close=")"><mml:mfrac><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>;</mml:mo></mml:math></disp-formula>
</p>
                  <p>if <mml:math id="jats-math-129" display="inline"><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math>, <mml:math id="jats-math-130" display="inline"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:math> should be imputed as,<disp-formula id="pst2209-disp-0015"><mml:math id="jats-math-131" display="block"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mi>Ber</mml:mi><mml:mfenced open="(" close=")"><mml:mfrac><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mfenced><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:math></disp-formula>
</p>
                  <p>When <mml:math id="jats-math-132" display="inline"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:math> is imputed, the conditional likelihood function for <mml:math id="jats-math-133" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> is<disp-formula id="pst2209-disp-0016"><label>(A1)</label><mml:math id="jats-math-134" display="block"><mml:msub><mml:mi>L</mml:mi><mml:mi>q</mml:mi></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:msubsup><mml:mi>q</mml:mi><mml:mi mathvariant="italic">Tk</mml:mi><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:msubsup><mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:msup><mml:mo>.</mml:mo></mml:math></disp-formula>Given the Beta prior <mml:math id="jats-math-135" display="inline"><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:msub><mml:mi>α</mml:mi><mml:mi>q</mml:mi></mml:msub><mml:msub><mml:mi>β</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mfenced></mml:math>, the posterior samples of <mml:math id="jats-math-136" display="inline"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> are drawn from<disp-formula id="pst2209-disp-0017"><mml:math id="jats-math-137" display="block"><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfenced open="{" close="}"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfenced open="{" close="}"><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>q</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math></disp-formula>
</p>
                  <p>When <mml:math id="jats-math-138" display="inline"><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:math> is imputed, the conditional likelihood function for <mml:math id="jats-math-139" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> is<disp-formula id="pst2209-disp-0018"><mml:math id="jats-math-140" display="block"><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi>τ</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mi mathvariant="italic">Pki</mml:mi></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msubsup><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:mo>.</mml:mo></mml:math></disp-formula>
</p>
                  <p>Similar to Lin and Yuan,<xref rid="pst2209-bib-0031" ref-type="bibr"><sup>31</sup></xref> we perform Taylor expansion of <mml:math id="jats-math-141" display="inline"><mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac></mml:msup></mml:math> at <mml:math id="jats-math-142" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math>, resulting in <mml:math id="jats-math-143" display="inline"><mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac></mml:msup><mml:mo>≈</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math>. Consequently, we approximate <mml:math id="jats-math-144" display="inline"><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi>τ</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math> as<disp-formula id="pst2209-disp-0019"><mml:math id="jats-math-145" display="block"><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi>τ</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>≈</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>L</mml:mi><mml:mo stretchy="true">˜</mml:mo></mml:mover><mml:mrow><mml:mi>τ</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:msup><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup><mml:msubsup><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:mo>.</mml:mo></mml:math></disp-formula>
</p>
                  <p>Based on the expression of <mml:math id="jats-math-146" display="inline"><mml:msub><mml:mover accent="true"><mml:mi>L</mml:mi><mml:mo stretchy="true">˜</mml:mo></mml:mover><mml:mrow><mml:mi>τ</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math>, <mml:math id="jats-math-147" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> follows the conjugate beta posterior distribution as<disp-formula id="pst2209-disp-0020"><mml:math id="jats-math-148" display="block"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math></disp-formula>
</p>
                  <p>Along the same line, <mml:math id="jats-math-149" display="inline"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math> follows the conjugate beta posterior distribution as<disp-formula id="pst2209-disp-0021"><mml:math id="jats-math-150" display="block"><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Beta</mml:mtext><mml:mfenced open="(" close=")" separators=","><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfenced open="{" close="}"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:munderover><mml:mfrac><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>U</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:msub></mml:mfrac><mml:mfenced open="{" close="}"><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ω</mml:mi><mml:mi mathvariant="italic">ki</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="italic">ki</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>τ</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math></disp-formula>
</p>
                  <sec id="pst2209-sec-0012">
                    <title>Proof of Theorem <xref rid="pst2209-mthst-0001" ref-type="statement">1</xref>
</title>
                    <p>If the issue of the semi‐competing risks is ignored, the utility function is constructed as<disp-formula id="pst2209-disp-0022"><mml:math id="jats-math-151" display="block"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:mover accent="true"><mml:mi>U</mml:mi><mml:mo stretchy="true">¯</mml:mo></mml:mover><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>00</mml:mn></mml:msub><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>01</mml:mn></mml:msub><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>11</mml:mn></mml:msub><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>00</mml:mn></mml:msub><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>00</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>01</mml:mn></mml:msub><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>01</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>10</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
</p>
                    <p>By comparing <mml:math id="jats-math-152" display="inline"><mml:mover accent="true"><mml:mi>U</mml:mi><mml:mo stretchy="true">¯</mml:mo></mml:mover><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced></mml:math> with <mml:math id="jats-math-153" display="inline"><mml:mi>U</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced></mml:math>, we get<disp-formula id="pst2209-disp-0023"><mml:math id="jats-math-154" display="block"><mml:mover accent="true"><mml:mi>U</mml:mi><mml:mo stretchy="true">¯</mml:mo></mml:mover><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced><mml:mo linebreak="goodbreak">−</mml:mo><mml:mi>U</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mi>k</mml:mi><mml:msub><mml:mi>π</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mi>π</mml:mi><mml:mrow><mml:mn>11</mml:mn><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>ζ</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo linebreak="goodbreak">−</mml:mo><mml:msub><mml:mi>ζ</mml:mi><mml:mn>11</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:math></disp-formula>
</p>
                  </sec>
                </sec>
              </app>
            </app-group>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
